In 2022, a group of patient engagement professionals across the life sciences industry began meeting informally to address a shared challenge:

While patient engagement was gaining recognition, the function itself lacked common standards, shared safeguards, and a clear professional identity.

What started as monthly virtual exchanges quickly revealed something larger. The field needed structure. Since then, PEPS has evolved from an informal network into a professional association dedicated to strengthening the foundations of patient engagement as a strategic discipline.

Our Mission and Vision

VISION

A future where patient engagement is meaningfully integrated and influential in the life sciences industry, driven by empowered professionals united as a global community delivering groundbreaking, patient-focused innovations.

MISSION

To unite patient engagement professionals across  pharmaceutical, biotechnology, or medical technology (Medtech) companies; amplify their collective voice, and foster a culture of co-design that shapes health strategies and products with patients, driving  systemic change across the life sciences ecosystem.

Our blueprint for Impact

We don't just talk about change—we architect it.

Guided by integrity, collaboration, and respect, PEPS  is a non-commercial forum where open dialogue and shared ownership strengthen our profession, free from individual promotion.

PEPS shape the future of the PE function, teams, and individual PE professionals globally by:

01

Shaping the Patient Engagement Profession
CORE GOAL

Develop capability frameworks and define high-quality PE standards.

FOCUS AREAS

Our Evolving Structure

PEPS has grown deliberately without losing agility. We began with a Steering Committee to launch the Society and represent the founding community.

As we matured, governance evolved into a Strategic Advisory Committee (SAC), focused on shaping long-term direction and safeguarding integrity. By shifting responsibilities and scaling our leadership teams in real-time, we ensure that the society remains lean, effective, and focused on driving the future of the industry.

Efficiency and adaptability are at the heart of the PEPS structure. From our initial Steering Committee to our current Strategic Advisory Committee (SAC), we prioritize a governance model that evolves as we do. By shifting responsibilities and scaling our leadership teams in real-time, we ensure that the society remains lean, effective, and focused on driving the future of the industry.

Founding Partners

We're proud to have Roche, Boehringer Ingelheim, Johnson & Johnson, and Sanofi as PEPS Founding Partners.

Their commitment signals a shared belief: patient engagement is maturing into a strategic driver of life science decision-making.

PROGRESS REQUIRES

01

Standards that strengthen trust and consistency

02

Impact evidence that resonates at the highest levels

03

Community that enables confident PE leadership

When industry leaders align around a shared ambition, progress accelerates for everyone. 

PEPS Members’ Hub

Gain insights into the latest industry trends, access a repository
of PE industry collective intelligence and join discussion groups.